Terveystalo Oyj
TTALF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.51 | 0.15 | 0.83 | 2.75 |
| FCF Yield | 2.22% | 1.13% | 4.74% | 2.22% |
| EV / EBITDA | 33.59 | 28.59 | 34.92 | 39.25 |
| Quality | ||||
| ROIC | 2.32% | 3.16% | 2.09% | 1.72% |
| Gross Margin | 60.06% | 60.28% | 59.20% | 58.69% |
| Cash Conversion Ratio | 1.46 | 0.66 | 3.67 | 2.24 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.12% | 1.71% | 2.10% | 2.00% |
| Free Cash Flow Growth | 80.70% | -77.23% | 129.66% | -7.63% |
| Safety | ||||
| Net Debt / EBITDA | 9.13 | 7.06 | 8.44 | 10.61 |
| Interest Coverage | 6.30 | 8.92 | 4.26 | 3.33 |
| Efficiency | ||||
| Inventory Turnover | 16.89 | 18.88 | 20.06 | 16.51 |
| Cash Conversion Cycle | -93.26 | -100.19 | -108.69 | -105.40 |